|
Oct 8
|
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
|
|
Sep 19
|
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
|
|
Sep 18
|
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
|
|
Sep 18
|
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
|
|
Jun 27
|
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
|
|
May 15
|
Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
|
May 14
|
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
|
|
May 14
|
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
|
|
Apr 9
|
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices
|
|
Apr 9
|
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
|
|
Apr 1
|
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
|
|
Mar 31
|
Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations
|
|
Mar 28
|
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
|
|
Mar 28
|
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
|
|
Nov 30
|
Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
|
|
Nov 29
|
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
|
|
Nov 29
|
UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea
|
|
Nov 29
|
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
|
|
Oct 24
|
Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
|
|
May 1
|
A Headache-Free Future? Vivos' POD Device Slashes Migraine Symptoms by 89% in Clinical Study
|